A case of recurrent herpes simplex 2 encephalitis, VZV reactivations, and dominant partial interferon-gamma-receptor-1 deficiency supports relevance of IFNgamma for antiviral defense in humans.
Julia Christine KörholzNicole RichterJochen SchäferCatharina SchuetzJoachim RoeslerPublished in: Molecular and cellular pediatrics (2020)
This case further confirms an enhanced risk for viral disease in IFNγR-deficient patients and a role of interferon gamma for human antiviral defense.